Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach
Mihai Lupu1, Diana Tudor1, Adriana Filip1
1Iuliu Hatieganu University of Medicine and Pharmacy, Department of Physiology, Cluj-Napoca, Romania.
Insights
This review explores iron
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
- Pathophysiology
Background:
- Iron's role in cardiovascular health is complex and not fully understood.
- While beneficial in chronic heart failure, its impact on acute events like myocardial infarction and stroke is understudied.
- Iron's redox properties may influence atherosclerosis, necrosis, and ferroptosis.
Purpose of the Study:
- To review the literature on iron's temporal effects in cardiovascular diseases.
- To elucidate the pathophysiological mechanisms of iron's involvement.
- To highlight current and potential treatment strategies.
Main Methods:
- Comprehensive literature review of studies on iron and cardiovascular diseases.
- Analysis of pathophysiological mechanisms involving iron's redox activity.
- Synthesis of findings related to acute and chronic cardiovascular conditions.
Main Results:
- Evidence suggests iron benefits chronic heart failure patients with deficiency.
- Acute cardiovascular events like myocardial infarction and stroke have limited randomized controlled trial data.
- Iron's dual redox nature is implicated in atherosclerosis, necrosis, and ferroptosis.
Conclusions:
- Further research is needed on iron's role in acute cardiovascular diseases.
- Understanding iron's complex mechanisms can inform targeted therapeutic interventions.
- Intravenous iron may be beneficial in specific cardiovascular contexts, warranting further investigation.
Abstract:
Iron interactions with the cardiovascular system were proposed about half a century ago, yet a clear-cut understanding of this micronutrient and its intricacies with acute and chronic events is still lacking. In chronic heart failure, patients with decreased iron stores appear to benefit from intravenous administration of metallic formulations, whereas acute diseases (e.g., myocardial infarction, stroke) are barely studied in randomized controlled trials in humans. However, proof-of-concept studies have indicated that the dual redox characteristics of iron could be involved in atherosclerosis, necrosis, and ferroptosis. To this end, we sought to review the currently available body of literature pertaining to these temporal profiles of heart diseases, as well as the pathophysiologic mechanism by which iron enacts, underlining key points related to treatment options.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis III: Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...


